Sustainable marine biotech

The medicine of tomorrow

Hofseth BioCare is processing marine raw material into products to enhance global health.

Reasons to invest
Our value

Research & Development

Hofseth BioCare is processing marine raw material into products to enhance global health.

Read more

Latest news

Featured

Green light for COVID-19 study

30.06.2020 - Hofseth BioCare is now recruiting patients for its Covid-19 study, after receiving approval from the Canadian authorities.

Read more
Factory
The Hofseth BioCare approach
Pipett01
Could salmon oil work as treatment of COVID-19 patients?
Pro Go 1200x490
Research agreement with Stanford University

Latest stock exchange notices

Stock Exhange Notices

CORRECTION: SHARE CAPITAL DECREASE REGISTERED – NEW PAR VALUE

12.08.2020

SHARE CAPITAL DECREASE REGISTERED – NEW PAR VALUE

12.08.2020

HBC starts its accelerated COVID-19 Phase 2 clinical trial of OmeGo® salmon oil to decrease Acute Respiratory Distress Syndrome and the need for assisted respiration

30.06.2020

HBC has begun protocol development for its accelerated Phase 2 clinical trial with OmeGo® to decrease Acute Respiratory Distress Syndrome and the need for assisted respiration in COVID-19 patients

26.05.2020

Completed Annual General Meeting

25.05.2020